These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 24615247)
41. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871 [TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965 [TBL] [Abstract][Full Text] [Related]
43. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Kreimer AR; Clifford GM; Snijders PJ; Castellsagué X; Meijer CJ; Pawlita M; Viscidi R; Herrero R; Franceschi S; Int J Cancer; 2005 Jun; 115(2):329-32. PubMed ID: 15688391 [TBL] [Abstract][Full Text] [Related]
44. Obesity and head and neck cancer risk and survival by human papillomavirus serology. Tan X; Nelson HH; Langevin SM; McClean M; Marsit CJ; Waterboer T; Pawlita M; Kelsey KT; Michaud DS Cancer Causes Control; 2015 Jan; 26(1):111-9. PubMed ID: 25398682 [TBL] [Abstract][Full Text] [Related]
45. Demographic and risk factors in patients with head and neck tumors. Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944 [TBL] [Abstract][Full Text] [Related]
46. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Agrawal Y; Koch WM; Xiao W; Westra WH; Trivett AL; Symer DE; Gillison ML Clin Cancer Res; 2008 Nov; 14(21):7143-50. PubMed ID: 18981014 [TBL] [Abstract][Full Text] [Related]
47. Cancer Immunology and HPV. Wollenberg B Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544 [TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Klussmann JP; Weissenborn SJ; Wieland U; Dries V; Eckel HE; Pfister HJ; Fuchs PG Med Microbiol Immunol; 2003 Aug; 192(3):129-32. PubMed ID: 12920586 [TBL] [Abstract][Full Text] [Related]
49. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer. Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267 [TBL] [Abstract][Full Text] [Related]
50. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197 [TBL] [Abstract][Full Text] [Related]
51. The role of human papillomavirus infection in head and neck cancers. Syrjänen S Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622 [TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus serology and tobacco smoking in a community control group. Kelsey KT; Nelson HH; Kim S; Pawlita M; Langevin SM; Eliot M; Michaud DS; McClean M BMC Infect Dis; 2015 Jan; 15():8. PubMed ID: 25572638 [TBL] [Abstract][Full Text] [Related]
53. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836 [TBL] [Abstract][Full Text] [Related]
54. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management. Tran NH; Sais D; Tran N J Med Virol; 2024 Jun; 96(6):e29746. PubMed ID: 38884391 [TBL] [Abstract][Full Text] [Related]
55. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer. Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665 [TBL] [Abstract][Full Text] [Related]
56. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence. Speel EJ Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529 [TBL] [Abstract][Full Text] [Related]
57. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest. Li C; Johnson DE Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999 [TBL] [Abstract][Full Text] [Related]
58. Prevalence and genotypes of human papillomavirus in saliva and tumor samples of head and neck cancer patients in Hungary. Hettmann A; Demcsák A; Bach Á; Decsi G; Dencs Á; Pálinkó D; Rovó L; Terhes G; Urbán E; Buzás K; Nagy K; Takács M; Minarovits J Infect Genet Evol; 2018 Apr; 59():99-106. PubMed ID: 29408738 [TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer. Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411 [TBL] [Abstract][Full Text] [Related]